Search - tctmd.com

Displaying 1 - 20 of 297

Sort: Relevancy | Date

News Daily News

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

Todd Neale

December 29, 2021

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Todd Neale

December 27, 2021

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Daily News

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

L.A. McKeown

December 17, 2021

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

News Daily News

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

Yael L. Maxwell

December 14, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Daily News

New Scientific Statement Seeks to Standardize Cardiac Surgery Trials

Yael L. Maxwell

December 08, 2021

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Daily News

Statins Underprescribed in PAD Before and After Interventions

L.A. McKeown

December 03, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

News Daily News

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

Michael O'Riordan

November 29, 2021

News Conference News AHA 2021

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Michael O'Riordan

November 22, 2021

Advertisement

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

FDA Approves Two Additional Indications for Rivaroxaban in Children

Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions

Discharge Safe as Early as a Day After Primary PCI for STEMI

Risk Factors Still Matter for Patients With Zero CAC Score: MESA

British Medical Groups Express Concern About Inclisiran Rollout

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

New Scientific Statement Seeks to Standardize Cardiac Surgery Trials

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

Statins Underprescribed in PAD Before and After Interventions

Another Study Links Stopping Statins to MACE in the Elderly

December 2021 News Roundup

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

ApoB Gains Ground as Best Lipid Predictor of MI Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content